On-chip immunofluorescence analysis of single cervical cells using an electroactive microwell array with barrier for cervical screening.
Makoto TakeuchiKazunori NagasakaMina YoshidaYoshiko KawataYuko MiyagawaSaori TagoHaruko HiraikeOsamu Wada-HiraikeKatsutoshi OdaYutaka OsugaTomoyuki FujiiTakuya AyabeSoo Hyeon KimTeruo FujiiPublished in: Biomicrofluidics (2019)
Several specific tests for cervical screening have been developed recently, including p16/Ki67 dual immunostaining for diagnosing high-risk human papillomavirus positive squamous intraepithelial lesion in the cervix. However, manual screening of cells in an entire glass slide is currently a standard clinical procedure for quantification and interpretation of immunocytochemical features of the cells. Here, we developed a microfluidic device containing an electroactive microwell array with barriers (EMAB) for highly efficient single-cell trapping followed by on-chip immunofluorescence analysis with minimum loss of the sample. EMAB utilizes patterned electrodes at the bottom of cell-sized microwells to trap single cells using dielectrophoresis (DEP) and cell-holding structures behind the microwells to stabilize the position of trapped cells even without DEP. Using the device, we evaluated the performance of p16/Ki67 dual immunostaining of HeLa cells on the chip. The device shows 98% cell-trapping efficiency as well as 92% cell-holding efficiency against the fixed HeLa cells, and we successfully demonstrated high-efficiency on-chip immunofluorescence analysis with minimal loss of sample. p16/Ki67 dual immunostaining using EMAB may be useful for complementary tests for cervical screening in confirming the histopathological diagnosis.
Keyphrases
- induced apoptosis
- cell cycle arrest
- single cell
- high throughput
- cell death
- endoplasmic reticulum stress
- oxidative stress
- high efficiency
- highly efficient
- signaling pathway
- squamous cell carcinoma
- stem cells
- cell therapy
- pi k akt
- low grade
- high grade
- minimally invasive
- radiation therapy
- neoadjuvant chemotherapy
- mass spectrometry
- mesenchymal stem cells
- lymph node
- bone marrow
- locally advanced